BrightInsight’s Patient App, developed with Sanofi, shows positive impact in patient treatment adherence and persistenceSAN JOSE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BrightInsight, Inc. (“BrightInsight”), a leader in digital health solutions, today shared new data from its collaboration with Sanofi and its partner, Regeneron, highlighting the positive impact of the Patient App on adherence and persistence for one of Sanofi and Regeneron’s key biologic therapies.
Stephen Ubl Joins BrightInsight’s Board of DirectorsSAN JOSE, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for digital health solutions, has announced that Stephen J. Ubl, President and CEO of Pharmaceutical Research and Manufacturers of America (PhRMA), has been appointed as an independent director to its Board of Directors. Mr. Ubl brings over 25 years of leadership experience in the healthcare sector to BrightInsight. This strategic addition comes as the company continues to prove sustained impact, at scale, across various disease areas and therapeutic fields.
BrightInsight Expands Global Digital Partnership with Sanofi to Build Drug Companion Apps for its Major Specialty TherapiesFollowing the success of the MyWay app in the US and Germany, the partners will expand brand-oriented digital health companion apps
BrightInsight Expands its Partnership with Google Cloud to Enhance the Patient Journey Through Generative AIBrightInsight is modernizing its development processes and patient companion apps with Google’s Gemini models, MedLM, and Vertex AI
BrightInsight Recognized Among Newsweek’s World’s Best Digital Health Companies 2024 ListSAN JOSE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- BrightInsight, Inc., the trusted partner and de-facto platform driving value for top biopharma compliant digital health solutions, is thrilled to announce it has been named to Newsweek’s list of The World’s Best Digital Health Companies 2024. This recognition comes on the heels of BrightInsight being named to Forbes 2024 List of America’s Best Startup Employers earlier this month.
BrightInsight Named to Forbes 2024 List of America's Best Startup EmployersFor the second consecutive year, BrightInsight is recognized for its employer reputation, employee satisfaction and growth
BrightInsight Ranked 307th Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500Multiple global digital launches, product and platform enhancements and new partnerships in 2023 contributed to 431% revenue growth for biopharma and medtech’s preferred digital health platform
BrightInsight Named Leader in the Healthcare IoT Solutions Industry with Frost & Sullivan’s 2023 Global Company of the Year AwardThe best-in-class BrightInsight Platform accelerates the time to market for patient apps that enable biopharma companies to differentiate their therapies and enhance the patient journey
BrightInsight Named to Fierce Medtech’s 2022 Fierce 15 ListSAN JOSE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today that the company has been named to Fierce Medtech’s 2022 Fierce 15. The Fierce Medtech’s Fierce 15 spotlights the most exciting startups in medtech.
BrightInsight Ranked 217th Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™701% revenue growth underscores BrightInsight’s position as the de facto digital health platform for the world’s top biopharma and medtech companies
BrightInsight Inks Enterprise Agreement with CSL Behring for Digital Health Solutions Across Brand PortfolioFollowing success of Hizentra App, CSL Behring and BrightInsight expand partnership to build apps for rare disease medicines across the globe
